Compound polysaccharide anti-hemorrhagic thin film and preparation method thereof

A technology of compound polysaccharide and film, applied in pharmaceutical formulations, pharmaceutical sciences, absorption pads, etc., can solve the problems of easy detachment of tourniquets, poor hemostatic effect, congestion and other problems, and achieve shortened bleeding time, obvious hemostatic effect, and convenient use. Effect

Inactive Publication Date: 2016-07-20
SUZHOU BEC BIOLOGICAL TECH
View PDF6 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Oxidized cellulose, fibrin glue and synthetic glue point pricking have been used for local hemostasis trials; molecular sieves and chitosan are the latest generation of local hemostasis trials, and their effects and safety are currently being studied; recombinant Activated coagulation factor VII (FVIIa) is the most ideal hemostatic agent for trauma hemostasis, but its safety for trauma patients has yet to be investigated through multiple randomized controlled experiments.
[0003] The traditional methods of hemostasis mainly include suturing, pressing and dressing. The main hemostatic products include first aid kits, four-head bands, hemostatic gauze, tourniquets and bandages. The main method, but there will be great defects during or after use, so it is greatly limited in clinical application
For example, suture hemostasis is very effective for traumatic bleeding of soft tissues and large blood vessels, but the effect of hemostasis on solid organs with high fragility and rich blood flow is not ideal, and it is very easy to cause needle holes or hemorrhagic tissue damage. This affects the normal functions of the kidneys, brain ...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound polysaccharide anti-hemorrhagic thin film and preparation method thereof
  • Compound polysaccharide anti-hemorrhagic thin film and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Composite polysaccharide hemostatic film, the components and the mass parts of each component are as follows: 10 parts of chitosan, 2 parts of glucose, 3 parts of methyl cellulose, 1 part of gelatin, 4 parts of pectin, 4 parts of sodium trimetaphosphate, 8 parts of alcohol glycerin, 5 parts of agar, 2 parts of sorbic acid, 5 parts of sodium alginate, 3 parts of Panax notoginseng, 1 part of sodium fumarate, 2 parts of Burnet.

[0021] The preparation method comprises the steps of:

[0022] 1) Mix chitosan, glucose, methylcellulose and sodium alginate in proportion by mass, add polyol, heat up to 90°C, stir for 45 minutes, then add sorbic acid and continue stirring for 13 minutes to obtain a mixed sugar liquid;

[0023] 2) Mix gelatin, pectin, agar, sodium fumarate, sodium trimetaphosphate, Panax notoginseng and Burnet evenly, add to the mixed sugar solution in step 1), heat to 75°C, stir for 60 minutes, and polysaccharide film liquid;

[0024] 3) Pour the polysaccharid...

Embodiment 2

[0026] Compound polysaccharide hemostatic film, the components and the mass parts of each component are as follows: 20 parts of chitosan, 8 parts of glucose, 6 parts of methyl cellulose, 5 parts of gelatin, 7 parts of pectin, 7 parts of sodium trimetaphosphate, multi-component 20 parts of alcohol glycerin, 8 parts of agar, 8 parts of sorbic acid, 10 parts of sodium alginate, 6 parts of Panax notoginseng, 3 parts of sodium fumarate, and 5 parts of Burnet.

[0027] The preparation method comprises the steps of:

[0028] 1) Mix chitosan, glucose, methylcellulose and sodium alginate in proportion by mass, add polyol, heat up to 90°C, stir for 45 minutes, then add sorbic acid and continue stirring for 13 minutes to obtain a mixed sugar liquid;

[0029] 2) Mix gelatin, pectin, agar, sodium fumarate, sodium trimetaphosphate, Panax notoginseng and Burnet evenly, add to the mixed sugar solution in step 1), heat to 75°C, stir for 60 minutes, and polysaccharide film liquid;

[0030] 3)...

Embodiment 3

[0032] Compound polysaccharide hemostatic film, the components and the mass parts of each component are as follows: 12 parts of chitosan, 4 parts of glucose, 4 parts of methyl cellulose, 2 parts of gelatin, 5 parts of pectin, 5 parts of sodium trimetaphosphate, multi-component 10 parts of alcohol glycerin, 6 parts of agar, 4 parts of sorbic acid, 6 parts of sodium alginate, 4 parts of Panax notoginseng, 2 parts of sodium fumarate, and 3 parts of Burnet.

[0033] The preparation method comprises the steps of:

[0034] 1) Mix chitosan, glucose, methylcellulose and sodium alginate in proportion by mass, add polyol, heat up to 90°C, stir for 45 minutes, then add sorbic acid and continue stirring for 13 minutes to obtain a mixed sugar liquid;

[0035] 2) Mix gelatin, pectin, agar, sodium fumarate, sodium trimetaphosphate, Panax notoginseng and Burnet evenly, add to the mixed sugar solution in step 1), heat to 75°C, stir for 60 minutes, and polysaccharide film liquid;

[0036] 3) ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a compound polysaccharide anti-hemorrhagic thin film and a preparation method thereof.The thin film is prepared from, by mass, 10-20 parts of chitosan, 2-8 parts of glucose, 3-6 parts of methylcellulose, 1-5 parts of gelatin, 4-7 parts of pectin, 4-7 parts of sodium trimetaphosphate, 8-20 parts of polyhydric alcohols, 5-8 parts of agar, 2-8 parts of sorbic acid, 5-10 parts of sodium alginate, 3-6 parts of panax notoginseng, 1-3 parts of sodium fumarate and 2-5 parts of sanguisorba officinalis.A polysaccharide serves as a matrix, proper anti-hemorrhagic components and auxiliaries are added, and the film-shaped anti-hemorrhagic material is prepared.Compared with conventional powder or spray, the film-shaped anti-hemorrhagic material can stop bleeding in two aspects synchronously.In the early time of bleeding, the film body is similar to tourniquet and can quickly stop bleeding, the anti-hemorrhagic components in the film synchronously stop bleeding at the same time, and the thin film has dual anti-hemorrhagic functions, greatly shortens bleeding time and is obvious in anti-hemorrhagic effect and convenient to use.

Description

technical field [0001] The invention belongs to the technical field of medical hemostatic materials, in particular to a composite polysaccharide hemostatic film and a preparation method thereof. Background technique [0002] Bleeding remains the leading cause of death in trauma patients. At present, the effective control method for aortic bleeding only stays on the operating table, but for field or acute trauma bleeding patients, the best treatment time is often missed due to excessive blood loss on the way to the emergency room after bleeding, so , How to effectively control bleeding in the first time has become the most challenging and important task at present. Compared with some traditional methods of surgical control of hemostasis, some advanced hemostatic materials and test punctures have recently appeared, which can be used for field hemostasis or emergency life-saving hemostasis. Oxidized cellulose, fibrin glue and synthetic glue point pricking have been used for l...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61L15/28A61L15/44A61L15/40A61L15/42
CPCA61L15/28A61L15/40A61L15/42A61L15/44A61L2300/30A61L2300/418A61L2400/04C08L5/08C08L5/12C08L5/06C08L1/28
Inventor 李苏杨李文遐徐勤霞
Owner SUZHOU BEC BIOLOGICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products